GlassScriptPhysician profile
Kevin A Malone
NPI 1053389361
$5,709.77
in general payments reported to CMS, 2019-2025
22 companies · $1,043 in 2025
The $1,043 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $570 · 2021: $538 · 2022: $1,055 · 2023: $385 · 2024: $1,578 · 2025: $1,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,006.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,692.42 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $945.34 | 2022-2025 | |
| Lilly USA, LLC | $573.79 | 2019-2025 | Mounjaro, Kisunla, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $325.94 | 2020-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $325.19 | 2019-2022 | |
| Glaxosmithkline, LLC. | $268.56 | 2020-2025 | Trelegy Ellipta |
| Mannkind Corporation | $253.28 | 2020-2023 | Afrezza |
| Novo Nordisk INC | $233.52 | 2020-2024 | |
| Sanofi-Aventis U.S. LLC | $195.99 | 2019-2022 | |
| Abbvie INC. | $174.03 | 2019-2021 | |
| Heartflow, INC. | $121.76 | 2025 | |
| Eisai INC. | $119.92 | 2024 | |
| Dexcom, INC. | $80.27 | 2019-2023 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $79.84 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $75.90 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $57.37 | 2023-2024 | |
| Tempus Ai, INC | $53.87 | 2024 | |
| Edwards Lifesciences Corporation | $47.92 | 2025 | Sapien 3 Ultra Resilia |
| Insulet Corporation | $26.66 | 2024 | Omnipod |
| Exact Sciences Corporation | $26.54 | 2024 | Cologuard Collection Kit |
| Allergan, INC. | $17.39 | 2020 | |
| Abbott Laboratories | $14.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.